BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32159578)

  • 41. Effect of magnetite nanoparticles on living rate of MCF-7 human breast cancer cells.
    Baba D; Seiko Y; Nakanishi T; Zhang H; Arakaki A; Matsunaga T; Osaka T
    Colloids Surf B Biointerfaces; 2012 Jun; 95():254-7. PubMed ID: 22486944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective bio-labeling and induced apoptosis of hematopoietic cancer cells using dual-functional polyethylenimine-caged platinum nanoclusters.
    Chen X; Zhou J; Yue X; Wang S; Yu B; Luo Y; Huang X
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1465-1470. PubMed ID: 30029883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selenium-doped hydroxyapatite biopapers with an anti-bone tumor effect by inducing apoptosis.
    Zhou ZF; Sun TW; Qin YH; Zhu YJ; Jiang YY; Zhang Y; Liu JJ; Wu J; He SS; Chen F
    Biomater Sci; 2019 Nov; 7(12):5044-5053. PubMed ID: 31552923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteotropic polypeptide nanoparticles with dual hydroxyapatite binding properties and controlled cisplatin delivery.
    de Miguel L; Popa I; Noiray M; Caudron E; Arpinati L; Desmaele D; Cebrián-Torrejón G; Doménech-Carbó A; Ponchel G
    Pharm Res; 2015 May; 32(5):1794-803. PubMed ID: 25504453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.
    Jain A; Sharma G; Kushwah V; Garg NK; Kesharwani P; Ghoshal G; Singh B; Shivhare US; Jain S; Katare OP
    Nanomedicine (Lond); 2017 Aug; 12(15):1851-1872. PubMed ID: 28703643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate-mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects.
    Fan Z; Wang Y; Xiang S; Zuo W; Huang D; Jiang B; Sun H; Yin W; Xie L; Hou Z
    J Mater Chem B; 2020 Mar; 8(9):1922-1934. PubMed ID: 32052817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two novel chiral tetranucleate copper-based complexes: crystal structures, nanoparticles, and inhibiting angiogenesis and the growth of human breast cancer by regulating the VEGF/VEGFR2 signal pathway in vitro.
    Zhang PL; Hou XX; Liu MR; Huang FP; Qin XY
    Dalton Trans; 2020 May; 49(18):6043-6055. PubMed ID: 32319484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
    Lee WH; Loo CY; Rohanizadeh R
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
    Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
    Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Controlled nanoparticle synthesis of Ag/Fe co-doped hydroxyapatite system for cancer cell treatment.
    Veerla SC; Kim DR; Kim J; Sohn H; Yang SY
    Mater Sci Eng C Mater Biol Appl; 2019 May; 98():311-323. PubMed ID: 30813033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles.
    Wang Y; Wang J; Hao H; Cai M; Wang S; Ma J; Li Y; Mao C; Zhang S
    ACS Nano; 2016 Nov; 10(11):9927-9937. PubMed ID: 27797178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The design and characterization of a novel beta-casein nano-vehicle loaded with platinum anticancer drug for drug delivery.
    Divsalar A; Razmi M; Saboury AA; Seyedarabi A
    Anticancer Agents Med Chem; 2014; 14(6):892-900. PubMed ID: 24521150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unfolded Protein Response is Involved in Trans-Platinum (II) Complex-Induced Apoptosis in Prostate Cancer Cells via ROS Accumulation.
    Karakas D; Cevatemre B; Oral AY; Yilmaz VT; Ulukaya E
    Anticancer Agents Med Chem; 2019; 19(9):1184-1195. PubMed ID: 30963984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
    Shahsavar F; Bozorgmehr M; Mirzadegan E; Abedi A; Lighvan ZM; Mohammadi F; Safari N; Amani V; Zarnani AH
    Anticancer Agents Med Chem; 2016; 16(3):393-403. PubMed ID: 26899296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and characterisation of arsenic nanoparticles and its interaction with DNA and cytotoxic potential on breast cancer cells.
    Subastri A; Arun V; Sharma P; Preedia Babu E; Suyavaran A; Nithyananthan S; Alshammari GM; Aristatile B; Dharuman V; Thirunavukkarasu C
    Chem Biol Interact; 2018 Nov; 295():73-83. PubMed ID: 29277637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selenium nanoparticles: A potent chemotherapeutic agent and an elucidation of its mechanism.
    Menon S; Ks SD; R S; S R; S VK
    Colloids Surf B Biointerfaces; 2018 Oct; 170():280-292. PubMed ID: 29936381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sol-gel synthesis and cytotoxicity evaluation of selenium-doped cerium oxide nanoparticles for biomedical applications.
    Javid H; Amiri H; Hashemi SF; Reihani A; Esparham A; Hashemy SI
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3437-3447. PubMed ID: 37962586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PSMA-targeted melanin-like nanoparticles as a multifunctional nanoplatform for prostate cancer theranostics.
    Dai L; Shen G; Wang Y; Yang P; Wang H; Liu Z
    J Mater Chem B; 2021 Jan; 9(4):1151-1161. PubMed ID: 33434248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.